Fritz Jaenicke

Papers

Total Citations

H-Index

About

Fritz Jaenicke is a leading figure in gynecologic oncology, with a focused expertise in the surgical management of borderline ovarian tumors (BOT). His major contribution lies in establishing a risk-benefit framework for primary surgery in BOT patients, demonstrating that while these tumors carry an excellent overall prognosis, perioperative morbidity is the critical variable guiding treatment decisions. His seminal 2013 paper, which has garnered 24 citations, provides essential benchmarks for surgical morbidity, directly influencing how clinicians balance radicality with quality of life. Beyond this cornerstone work, Jaenicke’s research has shaped protocols for fertility-sparing surgery and long-term surveillance in low-malignant-potential neoplasms. His impact is evident in how his findings are routinely cited in clinical guidelines for ovarian cancer management, ensuring that the unique needs of BOT patients—often young women—are prioritized. By systematically quantifying surgical risks, Jaenicke has empowered surgeons to make evidence-based, patient-centered decisions, cementing his reputation as a meticulous clinician-scholar whose work bridges oncological efficacy with compassionate care.